Veterinary Medicine Information website

Lidokel-Adrenalin vet. 20 mg/ml + 0,036 mg/ml injeksjonsvæske, oppløsning til hest, hund, kalv og spedgris

Authorised
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
Lidokel-Adrenalin vet. 20 mg/ml + 0,036 mg/ml injeksjonsvæske, oppløsning til hest, hund, kalv og spedgris
Active substance:
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride monohydrate
Target species:
  • Dog
  • Horse
  • Cattle (calf)
  • Pig (newborn piglet)
Route of administration:
  • Infiltration
  • Infusion
  • Epidural use
  • Transdermal use

Product details

Active substance and strength:
  • EPINEPHRINE BITARTRATE
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Infiltration
    • Horse
      • Kidney
        1
        day
      • Liver
        1
        day
    • Cattle (calf)
      • Meat and offal
        7
        day
  • Infusion
    • Cattle (calf)
      • Meat and offal
        7
        day
    • Horse
      • Kidney
        7
        day
      • Liver
        1
        day
  • Epidural use
    • Horse
      • Kidney
        1
        day
      • Liver
        1
        day
    • Cattle (calf)
      • Meat and offal
        7
        day
  • Transdermal use
    • Pig (newborn piglet)
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetpharma AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 0000-08091
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 23/12/2021
Download
Norwegian (PDF)
Published on: 13/05/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 13/05/2025
Download